bioplatin (NTPX-07)
/ Rasayani Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 17, 2024
Bioplatin, a novel oral platinum-based compound: Potential for cancer prevention and treatment in SCID mice using xenograft models of prostate cancer
(ESMO Asia 2024)
- "The observed effects are probably due to direct cytotoxicity or interactions with innate immune components, as SCID mice lack adaptive immunity. Further investigation is warranted to understand the exact mechanism of action or involvement of any immunological pathways."
Preclinical • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1